554 related articles for article (PubMed ID: 27573769)
1. Endoscopic Treatment of Early Barrett's Neoplasia: Expanding Indications, New Challenges.
Pech O
Adv Exp Med Biol; 2016; 908():99-109. PubMed ID: 27573769
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
[TBL] [Abstract][Full Text] [Related]
3. Barrett's: evolving techniques for dysplasia detection and endoscopic resection.
Manner H; Pech O; Ell C
Semin Thorac Cardiovasc Surg; 2010; 22(4):321-9. PubMed ID: 21549272
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic eradication therapy for mucosal neoplasia in Barrett's esophagus.
Dunbar KB
Curr Opin Gastroenterol; 2013 Jul; 29(4):446-53. PubMed ID: 23703368
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study.
van Vilsteren FG; Alvarez Herrero L; Pouw RE; Visser M; Ten Kate FJ; van Berge Henegouwen MI; Schoon EJ; Weusten BL; Bergman JJ
Endoscopy; 2012 Dec; 44(12):1096-104. PubMed ID: 23108809
[TBL] [Abstract][Full Text] [Related]
6. Long-term durability of radiofrequency ablation for Barrett's-related neoplasia.
Haidry R; Lovat L
Curr Opin Gastroenterol; 2015 Jul; 31(4):316-20. PubMed ID: 26039723
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic therapy of Barrett's esophagus.
Pech O; Ell C
Curr Opin Gastroenterol; 2009 Sep; 25(5):405-11. PubMed ID: 19474724
[TBL] [Abstract][Full Text] [Related]
9. New directions in endoscopic therapy of Barrett' s esophagus.
Konda Vani JA; Chennat J; Waxman I
Minerva Gastroenterol Dietol; 2010 Dec; 56(4):421-35. PubMed ID: 21139541
[TBL] [Abstract][Full Text] [Related]
10. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.
Pech O; Behrens A; May A; Nachbar L; Gossner L; Rabenstein T; Manner H; Guenter E; Huijsmans J; Vieth M; Stolte M; Ell C
Gut; 2008 Sep; 57(9):1200-6. PubMed ID: 18460553
[TBL] [Abstract][Full Text] [Related]
11. Management of Nodular Neoplasia in Barrett's Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection.
Belghazi K; Bergman JJGHM; Pouw RE
Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):461-470. PubMed ID: 28577767
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus.
Nijhawan PK; Wang KK
Gastrointest Endosc; 2000 Sep; 52(3):328-32. PubMed ID: 10968845
[TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of radiofrequency ablation following endoscopic submucosal dissection for Barrett's neoplasia.
Subramaniam S; Kandiah K; Chedgy F; Meredith P; Longcroft-Wheaton G; Bhandari P
Dis Esophagus; 2018 Mar; 31(3):. PubMed ID: 29211875
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection for Endoscopic Therapy of Barrett's Esophagus-related Neoplasia.
Kothari S; Kaul V
Gastroenterol Clin North Am; 2015 Jun; 44(2):317-35. PubMed ID: 26021197
[TBL] [Abstract][Full Text] [Related]
15. Ablation of residual Barrett's epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study).
Manner H; Rabenstein T; Pech O; Braun K; May A; Pohl J; Behrens A; Vieth M; Ell C
Endoscopy; 2014 Jan; 46(1):6-12. PubMed ID: 24353120
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia.
Pouw RE; Wirths K; Eisendrath P; Sondermeijer CM; Ten Kate FJ; Fockens P; Devière J; Neuhaus H; Bergman JJ
Clin Gastroenterol Hepatol; 2010 Jan; 8(1):23-9. PubMed ID: 19602454
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic versus surgical therapy for Barrett's esophagus neoplasia.
Smith I; Kahaleh M
Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):31-5. PubMed ID: 25160753
[TBL] [Abstract][Full Text] [Related]
19. Editorial: Resecting or burning: what should we do with the remaining barrett's epithelium after successful ER of neoplasia?
Pech O; Ell C
Am J Gastroenterol; 2009 Nov; 104(11):2693-4. PubMed ID: 19888235
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic therapy using radiofrequency ablation for esophageal dysplasia and carcinoma in Barrett's esophagus.
van Vilsteren FG; Bergman JJ
Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):55-74, vi. PubMed ID: 19951794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
